← Back to Search

Sleep loss and circadian alignment for Sleep (EW and EWD Trial)

N/A
Waitlist Available
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This study aims to determine whether abnormal bodily rhythms contribute to elevate the risk of diabetes, independently of the amount of sleep loss.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Sleep loss and circadian misalignmentExperimental Treatment1 Intervention
Group II: Sleep loss and circadian alignmentExperimental Treatment1 Intervention
Sleep restriction without circadian misalignment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fixed restricted bedtimes
2003
N/A
~50
Sleep restriction with circadian misalignment
2003
N/A
~50

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,054 Previous Clinical Trials
759,910 Total Patients Enrolled
14 Trials studying Sleep
1,459 Patients Enrolled for Sleep
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top